Niya Wanich is a Rheumatology/Immunology physician. OpenAlex indexes 12 publications with 990 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Inspire Medical Systems, Inc.Program year20252 payments
- Genentech USA, Inc.Program year20251 payment
- ARS Pharmaceuticals Operations, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
95.4%Histamine-1 Receptor Antagonist39.4%Levocetirizine Dihydrochloride70%Azelastine Hcl30%Part D≥58 patientsLeukotriene Receptor Antagonist28.9%Montelukast Sodium100%Part D≥56 patients+ 4 more classes in this area
Metabolism & gastrointestinal
2.6%Proton pump inhibitor2.6%Pantoprazole Sodium100%Part D<11 patientsDermatology
2%Interleukin-4 Receptor alpha Antagonist2%Dupixent Pen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- In vitro assessment of the allergenicity of a novel influenza vaccine produced in dog kidney cells in individuals with dog allergy
Annals of Allergy Asthma & Immunology
2010 - The Utility of a Customized Multi-Allergen Solid Phase to Screen for the Presence of Allergy in an HMO-Based Allergy Clinic
Journal of Allergy and Clinical Immunology
2010 - Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein
Journal of Allergy and Clinical Immunology
2009 - Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy
Journal of Allergy and Clinical Immunology
2009 - In vitro Assessment of the Allergenicity of Novel Influenza Vaccine Produced in Dog Kidney Cells in Subjects with Dog Allergy
Journal of Allergy and Clinical Immunology
2009
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”